Market Overview:
The global Advanced Wound Care Market was valued at USD 9.01 billion in 2016 and is projected to reach USD 13.05 billion by 2025, growing at a CAGR of 4.2% from 2017 to 2025.
Advanced wound care products are designed to treat more complex wounds andâ€"in order to be covered under insuranceâ€"usually require a doctor’s order. This includes hydrogels, hydrocolloids, alginates, and film and foam dressings.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Diabetic patients and linked chronic wounds
1.2 Growing geriatric population
1.3 Adoption of Evidence-based treatment of wounds
1.4 Advanced wound care products and easy availability
1.5 Awareness programs and seminars emphasizing on advanced wound care
2. Market Restraints
2.1 High cost of the products
Market Segmentation:
1. Global Advanced Wound Care Market, by Wound type:
1.1 Surgical Wounds
1.2 Ulcers
1.3 Pressure Ulcers
1.4 Diabetic Foot Ulcers
1.5 Venous Ulcers
1.6 Traumatic Wounds
1.7 Burns
1.8 Others
2. Global Advanced Wound Care Market, by End User:
2.1 Hospitals & Clinics
2.2 Home Care Settings
2.3 Other End Users
3. Global Advanced Wound Care Market, by Product:
3.1 Moist Wound Dressings
3.1.1 Foam Dressings
3.1.2 Hydrocolloid Dressings
3.1.3 Film Dressings
3.1.4 Alginate Dressings
3.1.5 Hydrogel Dressings
3.1.6 Collagen Dressings
3.2 Wound Therapy Devices
3.2.1 Pressure Relief Devices
3.2.2 Negative Pressure Wound Therapy Systems
3.2.3 Hyperbaric Oxygen Equipment
3.2.4 Electrical Stimulation Devices
3.2.5 Other Wound Therapy Devices
3.3 Active Wound Care
3.3.1 Artificial Skin and Substitutes
3.3.1.1 Autografts
3.3.1.2 Allografts and Xenografts
3.3.1.3 Other Substitutes
3.3.2 Topical Agents
4. Global Advanced Wound Care Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Smith & Nephew
2. Mölnlycke Health Care (A Part of Investor AB)
3. B. Braun
4. Convatec Group
5. Coloplast
6. Integra Lifesciences
7. 3M
8. Cardinal Health
9. Medtronic
10. Mimedx Group
11. Mpm Medical (RBC Life Sciences)
12. Paul Hartmann
13. Acelity L.P.
14. Key Innovators
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Advanced Wound Care Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL ADVANCED WOUND CARE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL ADVANCED WOUND CARE MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE
5.1 Overview
5.2 Surgical Wounds
5.3 Ulcers
5.4 Pressure Ulcers
5.5 Diabetic Foot Ulcers
5.6 Venous Ulcers
5.7 Traumatic Wounds
5.8 Burns
5.9 Others
6 GLOBAL ADVANCED WOUND CARE MARKET, BY END USER
6.1 Overview
6.2 Hospitals & Clinics
6.3 Home Care Settings
6.4 Other End Users
7 GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT
7.1 Overview
7.2 Moist Wound Dressings
7.2.1 Foam Dressings
7.2.2 Hydrocolloid Dressings
7.2.3 Film Dressings
7.2.4 Alginate Dressings
7.2.5 Hydrogel Dressings
7.2.6 Collagen Dressings
7.3 Wound Therapy Devices
7.3.1 Pressure Relief Devices
7.3.2 Negative Pressure Wound Therapy Systems
7.3.3 Hyperbaric Oxygen Equipment
7.3.4 Electrical Stimulation Devices
7.3.5 Other Wound Therapy Devices
7.4 Active Wound Care
7.4.1 Artificial Skin and Substitutes
7.4.2 Autografts
7.4.3 Allografts and Xenografts
7.4.4 Other Substitutes
7.5 Topical Agents
8 GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
9 GLOBAL ADVANCED WOUND CARE MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Smith & Nephew
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Mölnlycke Health Care
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 B. Braun
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Convatec Group
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Coloplast
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Integra Lifesciences
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 3M
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Cardinal Health
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Medtronic
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Mimedx Group
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
10.11 Mpm Medical
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Paul Hartmann
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments
10.13 Acelity L.P.
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments
10.14 Key Innovators
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments
11 Appendix
11.1 Related Reports